Press Releases

Press Releases

Date Title Files

Aug 06, 2020

Dynavax Announces Second Quarter 2020 Financial Results

Aug 03, 2020

TriSalus Life Sciences Acquires Dynavax’s SD-101 Oncology Program in Purchase Agreement for up to $250 million in Milestone Payments plus Royalties on Future Net Sales

Jul 30, 2020

Dynavax to Report Second Quarter 2020 Financial Results and Host Conference Call on August 6, 2020

Jul 23, 2020

Dynavax and Medigen Announce Collaboration to Develop a Novel Adjuvanted COVID-19 Vaccine Candidate

Jul 21, 2020

Dynavax Announces the Appointment of Two New Board Members

Jul 16, 2020

Dynavax and Mount Sinai Announce Collaboration to Develop a Universal Influenza Vaccine Candidate with CpG 1018 Adjuvant

Jul 14, 2020

Dynavax Announces First Participants Dosed in Phase 1 Clinical Trial Evaluating Medicago’s COVID-19 Vaccine Candidate with Dynavax’s CpG 1018 Adjuvant

Jul 08, 2020

Dynavax and Medicago Announce Collaboration to Develop a Novel Adjuvanted COVID-19 Vaccine Candidate

Jun 22, 2020

Dynavax to Present at the H.C. Wainwright Virtual Fireside Chat Series

Jun 19, 2020

Dynavax Announces First Participants Dosed in Phase 1 Clinical Trial Evaluating Clover Biopharmaceuticals’ COVID-19 S-Trimer Vaccine Candidate with CpG 1018 Adjuvant